Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hagemann

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaAndrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entityAndrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Molecular Cancer Therapeutics|November 28, 2018
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerJeanne M Quinn, Molly M Greenwade, Marguerite L Palisoul, et al.
Npj Imaging|June 3, 2026
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detectionSanskar Thakur, Yixiao Lin, Jinhua Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive TherapyEmese Zsiros, Priyanka Duttagupta, Denarda Dangaj, et al.
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Oncotarget|October 21, 2016
AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancerLaura M Divine, Mai R Nguyen, Eric Meller, et al.
Cancer|October 28, 2014
Clinical next-generation sequencing in patients with non-small cell lung cancerIan S Hagemann, Siddhartha Devarakonda, Christina M Lockwood, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2014
The Cancer Genomics Resource List 2014Mary M Zutter, Kenneth J Bloom, Liang Cheng, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinomaAndrea R Hagemann, Ian S Hagemann, Mark Cadungog, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entityAndrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Molecular Cancer Therapeutics|November 28, 2018
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian CancerJeanne M Quinn, Molly M Greenwade, Marguerite L Palisoul, et al.
Npj Imaging|June 3, 2026
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detectionSanskar Thakur, Yixiao Lin, Jinhua Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive TherapyEmese Zsiros, Priyanka Duttagupta, Denarda Dangaj, et al.
Gynecologic Oncology|August 27, 2023
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Oncotarget|October 21, 2016
AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancerLaura M Divine, Mai R Nguyen, Eric Meller, et al.
Cancer|October 28, 2014
Clinical next-generation sequencing in patients with non-small cell lung cancerIan S Hagemann, Siddhartha Devarakonda, Christina M Lockwood, et al.
Gynecologic Oncology|January 11, 2021
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 womenIan S Hagemann, Wei Deng, Richard J Zaino, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2014
The Cancer Genomics Resource List 2014Mary M Zutter, Kenneth J Bloom, Liang Cheng, et al.
Pageof 14